Background: The management of incontinence- associated dermatitis is important in caring for incontinent patients.

Incontinence- associated dermatitis (IAD) results from frequent exposure to urine or feces.

Core outcome sets may therefore be helpful to improve the value of clinical incontinence- associated dermatitis research.

The lack of comparability of clinical trial outcomes is a major challenge in the field of evidence-based incontinence- associated dermatitis prevention and treatment.

In 2010, an international consensus conference was held to review current evidence regarding the pathology, prevention, and management of incontinence- associated dermatitis (IAD).

Conclusion: Erythema, erosion, maceration, incontinence- associated dermatitis -related pain and patient satisfaction are the most important outcome domains to be measured in incontinence-associated dermatitis trials.

Study findings also suggest that prompt attention to incontinence events is needed to prevent moisture- associated skin damage (incontinence- associated dermatitis) even when absorbent pads are used.